Human neutrophil peptide-1 aggravates dextran sulfate sodium-induced colitis

Inflammatory Bowel Diseases

Volumn 18, Issue 4, 2012, Pages 667-675

  Hashimoto, Shinichi ^a   Uto, Hirofumi ^a   Kanmura, Shuji ^a   Sakiyama, Toshio ^a   Oku, Manei ^a   Iwashita, Yuji ^a   Ibusuki, Rie ^a   Sasaki, Fumisato ^a   Ibusuki, Kazunari ^a   Takami, Yoichiro ^a   Moriuchi, Akihiro ^a   Oketani, Makoto ^a   Ido, Akio ^a   Tsubouchi, Hirohito ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Dextran sulfate sodium; Human neutrophil peptide 1; IL 1 ; Macrophage; Ulcerative colitis

Indexed keywords

DEFENSIN 1; DEXTRAN SULFATE; GAMMA INTERFERON; INTERLEUKIN 1BETA; MYELOPEROXIDASE; PEPTIDE; PHOSPHATE BUFFERED SALINE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; COLITIS; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE ACTIVITY; DISEASE SEVERITY; ENZYME ACTIVITY; HISTOLOGY; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ALPHA-DEFENSINS; ANIMALS; CELLS, CULTURED; COLITIS; COLON; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-1BETA; INTESTINAL MUCOSA; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; MICE, SCID; PEROXIDASE; SEVERITY OF ILLNESS INDEX; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84858709667     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21855     Document Type: Article

References (39)

1. Podolsky DK. Inflammatory bowel disease. N Engl J Med. 2002;347:417-429. (Pubitemid 34851835)
2. Murch SH, Lamkin VA, Savage MO, et al. Serum concentrations of tumour necrosis factor alpha in childhood chronic inflammatory bowel disease. Gut. 1991;32:913-917.
3. Sawada K, Ohnishi K, Kosaka T, et al. Leukocytapheresis with leukocyte removal filter as new therapy for ulcerative colitis. Ther Apher. 1997;1:207-211. (Pubitemid 127685359)
4. Yamamoto T, Saniabadi AR, Umegae S, et al. Impact of selective leukocytapheresis on mucosal inflammation and ulcerative colitis: cytokine profiles and endoscopic findings. Inflamm Bowel Dis. 2006;12:719-726. (Pubitemid 44253756)
5. Ganz T. Defensins: antimicrobial peptides of vertebrates. C R Biol. 2004;327:539-549. (Pubitemid 38979504)
6. Ganz T, Lehrer RI. Defensins. Curr Opin Immunol. 1994;6:584-589. (Pubitemid 24249516)
7. Lichtenstein AK, Ganz T, Nguyen TM. Mechanism of target cytolysis by peptide defensins. Target cell metabolic activities, possibly involving endocytosis, are crucial for expression of cytotoxicity. J Immunol. 1988;140:2686-2694.
8. Van Wetering S, Mannesse-Lazeroms SP, Dijkman JH, et al. Effect of neutrophil serine proteinases and defensins on lung epithelial cells: modulation of cytotoxicity and IL-8 production. J Leukoc Biol. 1997;62:217-226. (Pubitemid 27380794)
9. Ganz T, Selsted ME, Szklarek D, et al. Defensins. Natural peptide antibiotics of human neutrophils. J Clin Invest. 1985;76:1427-1435. (Pubitemid 16193690)
10. Kanmura S, Uto H, Numata M, et al. Human neutrophil peptides 1-3 are useful biomarkers in patients with active ulcerative colitis. Inflamm Bowel Dis. 2009;15:909-917.
11. Liu CT, Lin HC, Yu CT, et al. The concentration-dependent chemokine release and pro-apoptotic effects of neutrophil-derived a-defensin- 1 on human bronchial and alveolar epithelial cells. Life Sci. 2007;80:749-758.
12. Jasmin G, Afsaneh S, Ulf F, et al. Chemoattraction of macrophages, T lymphocytes, and mast cells is evolutionarily conserved within the human α-defensin family. J Immunol. 2007;179:3958-3965.
13. Murthy SN, Cooper HS, Shim H, et al. Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporin. Dig Dis Sci. 1993;38:1722-1734. (Pubitemid 23271431)
14. Cooper HS, Murthy SN, Shah RS, et al. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest. 1993;69:238-249.
15. Qualls JE, Tuna H, Kaplan AM, et al. Suppression of experimental colitis in mice by CD11c+ dendritic cells. Inflamm Bowel Dis. 2009;15:236-247.
16. Khan WI, Motomura Y, Wang H, et al. Critical role of MCP-1 in the pathogenesis of experimental colitis in the context of immune and enterochromaffin cells. Am J Physiol Gastrointest Liver Physiol. 2006;291:G803-G811. (Pubitemid 44772006)
17. Ohda Y, Hori K, Tomita T, et al. Effects of hepatocyte growth factor on rat inflammatory bowel disease models. Dig Dis Sci. 2005;50:914-921. (Pubitemid 40684911)
18. Azuma YT, Hagi K, Shintani N, et al. PACAP provides colonic protection against dextran sodium sulfate induced colitis. J Cell Physiol. 2008;216:111-119. (Pubitemid 351813101)
19. Chertov O, Michiel DF, Xu L, et al. Identification of defensin-1, defensin-2, and CAP37/azurocidin as T-cell chemoattractant proteins released from interleukin-8-stimulated neutrophils. J Biol Chem. 1996;271:2935-2940. (Pubitemid 26055594)
20. Soehnlein O, Kai-Larsen Y, Frithiof R, et al. Neutrophil primary granule proteins HBP and HNP1-3 boost bacterial phagocytosis by human and murine macrophages. J Clin Invest. 2008;118:3491-3502.
21. Chaly YV, Paleolog EM, Kolesnikova TS, et al. Neutrophil alpha-defensin human neutrophil peptide modulates cytokine production in human monocytes and adhesion molecule expression in endothelial cells. Eur Cytokine Netw. 2000;11:257-266.
22. Aarbiou J, Ertmann M, van Wetering S, et al. Human neutrophil defensins induce lung epithelial cell proliferation in vitro. J Leukoc Biol. 2002;72:167-174.
23. Lichtenstein AK, Ganz T, Selsted ME, et al. In vitro tumor cell cytolysis mediated by peptide defensins of human and rabbit granulocytes. Blood. 1986;68:1407-1410. (Pubitemid 17228824)
24. Sakamoto N, Mukae H, Fujii T, et al. Differential effects of alpha- and beta-defensin on cytokine production by cultured human bronchial epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2005;288:508-513.
25. McKeown ST, Lundy FT, Nelson J, et al. The cytotoxic effects of human neutrophil peptide-1 (HNP1) and lactoferrin on oral squamous cell carcinoma (OSCC) in vitro. Oral Oncol. 2006;42:685-690. (Pubitemid 44094234)
26. Swidsinski A, Ladhoff A, Pernthaler A, et al. Mucosal flora in inflammatory bowel disease. Gastroenterology. 2002;22:44-54. (Pubitemid 34049193)
27. Ohkusa T, Okayasu I, Tokoi S, et al. Bacterial invasion into the colonic mucosa in ulcerative colitis. J Gastroenterol Hepatol. 1993;8:116-118. (Pubitemid 23092151)
28. Lampinen M, Rönnblom A, Amin K, et al. Eosinophil granulocytes are activated during the remission phase of ulcerative colitis. Gut. 2005;54:1714-1720. (Pubitemid 41697669)
29. Tollin M, Bergman P, Svenberg T, et al. Antimicrobial peptides in the first line defence of human colon mucosa. Peptides. 2003;24:523-530. (Pubitemid 36829340)
30. Cunliffe RN, Kamal M, Rose FR, et al. Expression of antimicrobial neutrophil defensins in epithelial cells of active inflammatory bowel disease mucosa. J Clin Pathol. 2002;55:298-304. (Pubitemid 34293399)
31. Zou H, Harrington JJ, Sugumar A, et al. Detection of colorectal disease by stool defensin assay: an exploratory study. Clin Gastroenterol Hepatol. 2007;5:865-868. (Pubitemid 47031063)
32. Ashitani J, Mukae H, Hiratsuka T, et al. Elevated levels of alpha-defensins in plasma and BAL fluid of patients with active pulmonary tuberculosis. Chest. 2002;121:519-526. (Pubitemid 34132993)
33. Soong LB, Ganz T, Ellison A, et al. Purification and characterization of defensins from cystic fibrosis sputum. Inflamm Res. 1997;46:98-102.
34. Perregaux DG, Bhavsar K, Contillo L, et al. Antimicrobial peptides initiate IL-1 beta posttranslational processing: a novel role beyond innate immunity. J Immunol. 2002;168:3024-3032. (Pubitemid 34211684)
35. Gruaz L, Delucinge-Vivier C, Descombes P, et al. Blockade of T cell contact-activation of human monocytes by high-density lipoproteins reveals a new pattern of cytokine and inflammatory genes. PLoS One. 2010;5:e9418.
36. Panyutich AV, Panyutich EA, Krapivin VA, et al. Plasma defensin concentrations are elevated in patients with septicemia or bacterial meningitis. J Lab Clin Med. 1993;122:202-207. (Pubitemid 23239152)
37. Hansen R, Thomson JM, El-Omar EM, et al. The role of infection in the aetiology of inflammatory bowel disease. J Gastroenterol. 2010;45:266-276.
38. Mayer L. Evolving paradigms in the pathogenesis of IBD. J Gastroenterol. 2010;45:9-16.
39. Kasten KR, Muenzer JT, Caldwell CC. Neutrophils are significant producers of IL-10 during sepsis. Biochem Biophys Res Commun. 2010;393:28-31.